Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MC4R | P32245 | 2/20 | 0.58 |
| ▸ | MC5R | P33032 | 2/20 | 0.58 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.56 |
| ▸ | MC3R | P41968 | 1/20 | 0.55 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.53 |
| ▸ | HTR2A | P28223 | 3/20 | 0.52 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.52 |
| ▸ | HTR2C | P28335 | 1/20 | 0.52 |
| ▸ | HTR2B | P41595 | 1/20 | 0.52 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | PNMT | P11086 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29860016 | 1.00 | MC4R (0.58) | MC4RMC5RCYP2A6CYP1A2MC3R | |
| Hydrochloric Acid SCHEMBL5169674 | 0.98 | MC4R (0.56) | MC4RMC5RCYP2A6CYP1A2MC3R | |
| Iodide SCHEMBL28811367 | 0.98 | MC4R (0.56) | MC4RMC5RCYP2A6CYP1A2MC3R | |
| Hydrochloric Acid SCHEMBL30098543 | 0.98 | MC4R (0.56) | MC4RMC5RCYP2A6CYP1A2MC3R | |
| Hydrochloric Acid SCHEMBL9530514 | 0.96 | MC4R (0.55) | MC4RMC5RCYP2A6CYP1A2MC3R | |
| SCHEMBL3721251 | 0.93 | ALDH1A1 (0.52) | MC4RMC5RCYP2A6CYP1A2MC3R | |
| Bicarbonate SCHEMBL9852517 | 0.90 | CYP1A2 (0.62) | MC4RMC5RCYP2A6CYP1A2MC3R | |
| Hydrochloric Acid SCHEMBL6563371 | 0.88 | KDM4E (0.58) | CYP2A6CYP1A2HTR2ATAAR1ALDH1A1 | |
| SCHEMBL132201 | 0.87 | MC4R (0.61) | MC4RMC5RCYP2A6CYP1A2MC3R | |
| SCHEMBL29120351 | 0.86 | TAAR1 (0.52) | CYP2A6CYP1A2HTR2ATAAR1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 600 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12075637-B2 | Perovskite solar cell and fabrication method thereof | CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED (CN) | 2024-08-27 | — | — | US | claimed |
| CN-117859209-A | Perovskite solar cell and preparation method thereof | 宁德时代新能源科技股份有限公司 | 2024-04-09 | — | — | CN | claimed |
| EP-4300602-A1 | PEROVSKITE SOLAR CELL AND PREPARATION METHOD THEREFOR | Contemporary Amperex Technology Co., Limited (CN) | 2024-01-03 | — | — | EP | claimed |
| US-20230403869-A1 | PEROVSKITE SOLAR CELL AND FABRICATION METHOD THEREOF | CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED (CN) | 2023-12-14 | — | — | US | claimed |
| WO-2023216132-A1 | PEROVSKITE SOLAR CELL AND PREPARATION METHOD THEREFOR | 宁德时代新能源科技股份有限公司 | 2023-11-16 | — | — | WO | claimed |
| CN-114892269-A | Reversible thermochromism two-dimensional halogenated lead perovskite single crystal and preparation method thereof | 上海电力大学 | 2022-08-12 | — | — | CN | claimed |
| WO-2018220646-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF (2S)-2-[(4R)-2-OXO-4-PROPYLTETRAHYDRO-1H-PYRROL-1-YL] BUTANAMIDE AND ITS INTERMEDIATES THEREOF | MSN LABORATORIES PRIVATE LIMITED, R&D CENTER (IN) | 2018-12-06 | — | — | WO | claimed |
| US-9435816-B2 | Deuterium free, stable isotope labeled 2-phenylethylamine hallucinogens and/or stimulants, methods of their preparation and their use | CHIRON AS (NO) | 2016-09-06 | — | — | US | claimed |
| US-20140227792-A1 | DEUTERIUM FREE, STABLE ISOTOPE LABELED 2-PHENYLETHYLAMINE HALLUCINOGENS AND/OR STIMULANTS, METHODS OF THEIR PREPARATION AND THEIR USE | CHIRON A/S (NO) | 2014-08-14 | — | — | US | claimed |
| EP-2744908-A1 | ENZYMATIC SYNTHESIS OF OPTICALLY ACTIVE CHIRAL AMINES | Embio Limited (IN) | 2014-06-25 | — | — | EP | claimed |
| US-20070185346-A1 | Kit for automated resolving agent selection and method thereof | VAIDYA NITEEN A | 2007-08-09 | — | — | US | claimed |
| US-20070100142-A1 | Reacting 1-amino-2-hydroxy-indene with a first protecting group containing a leaving group, followed by acetylation to prepare a protected intermediate, reacting with trifluoromethyl substituted ketone, then with metal oxide, hydrolysis, esterification, reaction with amino-picoline | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. | 2007-05-03 | — | — | US | claimed |
| WO-2007040959-A1 | STEREOSELECTIVE SYNTHESIS OF CERTAIN TRIFLUOROMETHYL-SUBSTITUTED ALCOHOLS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2007-04-12 | — | — | WO | claimed |
| WO-2007038277-A2 | RESOLUTION OF ALPHA-(PHENOXY) PHENYLACETIC ACID DERIVATIVES WITH NAPHTHYL-ALKYLAMINES | METABOLEX, INC. (US) | 2007-04-05 | — | — | WO | claimed |
| WO-2006064232-A1 | AMINE SALTS OF (-)-2-((2-(4-HYDROXYPHENYL)ETHYL)THIO)-3-(4-(2-(4-((METHYLSULFONYL)OXY) PHENOXY)ETHYL)PHENYL) PROPANOIC ACID | ASTRAZENECA AB (SE) | 2006-06-22 | — | — | WO | claimed |
| US-20050080261-A1 | Purine inhibitors of cyclin dependent kinase 2 and IkappaB-alpha | LUM ROBERT T (US) | 2005-04-14 | — | — | US | claimed |
| EP-1070048-A4 | CALCILYTIC COMPOUNDS | SMITHKLINE BEECHAM CORP (US) | 2001-11-07 | — | — | EP | claimed |
| EP-1070048-A1 | CALCILYTIC COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 2001-01-24 | — | — | EP | claimed |
| WO-1999051569-A1 | CALCILYTIC COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 1999-10-14 | — | — | WO | claimed |
| EP-0731790-A1 | TACHYKININ ANTAGONISTS | A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.R.L. (IT) | 1996-09-18 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140227792-A1 | DEUTERIUM FREE, STABLE ISOTOPE LABELED 2-PHENYLETHYLAMINE HALLUCINOGENS AND/OR STIMULANTS, METHODS OF THEIR PREPARATION AND THEIR USE | PNMT, HTR2C, HTR2A | MC4R 920/4885MC5R 625/4885CYP2A6 110/4885 |
| US-20050080261-A1 | Purine inhibitors of cyclin dependent kinase 2 and IkappaB-alpha | IKBKB, NFKB1, CDK4 | MC4R 1748/4885MC5R 924/4885CYP2A6 2515/4885 |
| US-20070100142-A1 | Reacting 1-amino-2-hydroxy-indene with a first protecting group containing a leaving group, followed by acetylation to prepare a protected intermediate, reacting with trifluoromethyl substituted ketone, then with metal oxide, hydrolysis, esterification, reaction with amino-picoline | ALDH7A1, AADAT, ALDH18A1 | MC4R 3091/4885MC5R 2174/4885CYP2A6 903/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.